Falls on Reports Novo Nordisk Is Developing New Obesity Treatments

tipranks.com/news/eli-lilly-stock-lly-falls-on-reports-novo-nordisk-is-developing-new-obesity-treatments

Eli Lilly’s (LLY) stock is down 2% on media reports that rival pharmaceutical company Novo Nordisk (NVO) has struck a deal that will help it develop new obesity treatments.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks'…

This story appeared on tipranks.com, 2025-05-15 07:19:52.845000.
The Entire Business World on a Single Page. Free to Use →